Shohei Nishimon

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Association Analysis of Inter-Alpha-Trypsin Inhibitor Genes in Schizophrenia.

Association Analysis of Inter-Alpha-Trypsin Inhibitor Genes in Schizophrenia.

Journal: Juntendo medical journal

Published: January 29, 2026

Relationship Between Clozapine Levels and Adverse Effects Evaluated by the GASS-C in Treatment-Resistant Schizophrenia.

Relationship Between Clozapine Levels and Adverse Effects Evaluated by the GASS-C in Treatment-Resistant Schizophrenia.

Journal: Human psychopharmacology

Published: January 12, 2026

An Association Study Between Educational Attainment-related Genes and Cognitive Functions in Japanese Patients with Schizophrenia Based on Full Pleiotropy.

An Association Study Between Educational Attainment-related Genes and Cognitive Functions in Japanese Patients with Schizophrenia Based on Full Pleiotropy.

Journal: Juntendo Iji zasshi = Juntendo medical journal

Published: March 13, 2023

Sleep Basic Research on Verifying the Effects of Natural Compounds on Wakefulness or Sleep.

Sleep Basic Research on Verifying the Effects of Natural Compounds on Wakefulness or Sleep.

Journal: Juntendo Iji zasshi = Juntendo medical journal

Published: August 11, 2021

Sake yeast induces the sleep-promoting effects under the stress-induced acute insomnia in mice.

Sake yeast induces the sleep-promoting effects under the stress-induced acute insomnia in mice.

Journal: Scientific reports

Published: April 27, 2021

Advances in the pharmacological management of non-24-h sleep-wake disorder.

Advances in the pharmacological management of non-24-h sleep-wake disorder.

Journal: Expert opinion on pharmacotherapy

Published: February 23, 2021

Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice.

Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice.

Journal: Neuroscience letters

Published: December 10, 2019

Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases.

Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases.

Journal: International journal of methods in psychiatric research

Published: November 09, 2019

Tasimelteon for treating non-24-h sleep-wake rhythm disorder.

Tasimelteon for treating non-24-h sleep-wake rhythm disorder.

Journal: Expert opinion on pharmacotherapy

Published: April 17, 2019

Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.

Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.

Journal: International journal of methods in psychiatric research

Published: October 28, 2018

Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia.

Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia.

Journal: Frontiers in psychiatry

Published: November 21, 2017

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: December 20, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026